› Forums › General Melanoma Community › Dr. Allison of MD Anderson article.
- This topic has 5 replies, 5 voices, and was last updated 4 years, 9 months ago by Rocco.
- Post
-
- February 7, 2020 at 5:20 am
Nice interview of Dr. Allison and his work in discovering Ipi and his on going research at MD Anderson! https://www.quantamagazine.org/nobel-laureate-james-p-allison-cures-cancers-with-immunotherapy-20200203/
- Replies
-
-
- February 7, 2020 at 1:04 pm
Thanks for this post, Ed! I’m being treated at MD Anderson and it was great to get an insight on an amazing doctor there. I really thought I was going to die – that this melanoma was going to take me out… after four ipi/nivo infusions, I don’t feel that way any more. Scans on 2/15 and am excited as can be. Fingers crossed. -
- February 7, 2020 at 2:30 pm
Great article about Dr. James Allison. Thank you very much Ed. In 2012, I had melanoma in my brain, both lungs, liver, kidney, gall bladder, left adrenal gland and spinal cord.
I received two brain surgeries plus Gamma Knife followed up with the very first clinical trial of Yervoy and Opdivo. Six and a half years later, all is well, still no cancer.
Jennifer, best wishes to you, everything is going to be all right. -
- February 7, 2020 at 3:34 pm
Thanks for sharing, Ed!!! OMG!!!!:From the article – per Allison ~ “The big pharmaceutical companies are now all players. Many, many early biotech firms are also trying to gain a presence. What you see, though, is that a lot of companies with patents on older, more conventional drugs are experimenting by combining them with checkpoints, just because they have the drugs. This is being done, in my opinion, without a lot of thought. A lot of them fail, but that information is usually lost because there’s no requirement for reporting. That’s still important information. So many combinations that are being tried are duplicative. It’s just a mess.”
Interviewer ~ “Are these trials being done on actual cancer patients?”
Allison ~ “Oh, yeah. They’re wasting patients. By that, I don’t just mean a large number of patients are not getting the treatments most likely to provide them benefit. Because we have a limited pool of patients, the most promising trials are not accruing sufficient patients fast enough to get these drugs to the clinic as quickly as we can.”
Interviewer ~ “Is that ethical?”
Allison ~ “I think it’s unethical. I think there shouldn’t be any trial where you don’t learn something.”
THAT!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! Is what I’ve been YELLING!!!!! Maybe folks will listen to HIM!!!!!!!!!!!!!!!!!!!!!!! Way to go Jennifer and John! Ratties Rock! – les
-
- February 8, 2020 at 4:43 am
This is my hero, my rock star. Simply put, thank you Dr. James Allison for your dedicated research – it saved my life.
Stage IV in Aug 2005, cancer free since Jan 2009 thanks to the 5 doses of Ipi I received in the MDX-010 trial only after having exhausted all then standard care options.
There are no words…..
-
- You must be logged in to reply to this topic.